Idiopathic pleuroparenchymal fibroelastosis (PPFE) - A case study of a rare entity

Rev Port Pneumol (2006). 2017 Nov-Dec;23(6):352-355. doi: 10.1016/j.rppnen.2017.06.006. Epub 2017 Aug 3.

Abstract

Idiopathic pleuroparenchymal fibroelastosis (IPPFE) was recognized as a rare new entity. We report the case of a 63 years old female suffering from progressive dyspnea and dry cough for three years. Two years before admission to our hospital, idiopathic pulmonary fibrosis (IPF) was diagnosed in another hospital and treatment with prednisolone and N-acetylcysteine (NAC) was commenced. At admission HRCT showed upper lobe dominant fibrosis and associated pleural thickening. Surgical biopsies were re-evaluated and revealed fibroelastosis with pleural thickening and a probable UIP pattern, consistent with idiopathic PPFE. Treatment with pirfenidone was initiated due to progression under prednisolone and NAC. Upper lobe predominant pleural thickening with associated subpleural fibrotic changes should raise suspicion of PPFE.

Keywords: Idiopathic pleuroparenchymal fibroelastosis; Pirfenidone; Rare lung disease.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Fibrosis
  • Humans
  • Middle Aged
  • Pleura / pathology*
  • Pleural Diseases / complications
  • Pleural Diseases / diagnosis*
  • Pulmonary Fibrosis / complications
  • Pulmonary Fibrosis / diagnosis*